Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma

doi:10.3748/wjg.v21.i8.2395

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7063)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

385

WORD

308

HTML

3750

Figures (1-3)

206

Tables (1-6)

148

Sum=4797

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

965

Download

1301

Sum=2266

Feb 28, 2015 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 28, 2015; 21(8): 2395-2404
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2395

Table 2 Objective response and disease control rate n (%)

	Objective response	Non-response	Disease control	Progressive disease
Treatment group (n = 102)	29 (28.4)	73 (71.6)	60 (58.8)	42 (41.2)
Conservative group (n = 20)	0 (0)	20 (100)	3 (15)	17 (85)
P value	0.003		< 0.001

Evaluation of tumor response was not possible in 17 (14.3% within treatment group) and 7 (25.9%, within conservative group) out of 146 patients.

Citation: Song DS, Nam SW, Bae SH, Kim JD, Jang JW, Song MJ, Lee SW, Kim HY, Lee YJ, Chun HJ, You YK, Choi JY, Yoon SK. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2015; 21(8): 2395-2404
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2395.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2395